Frequency and differentiation capacity of circulating LTC-IC mobilized by G-CSF or GM-CSF following chemotherapy: A comparison with steady-state bone marrow and peripheral blood

被引:10
作者
Benboubker, L
Binet, C
Cartron, G
Bernard, MC
Clement, N
Delain, M
Degenne, M
Desbois, I
Colombat, P
Domenech, J
机构
[1] Fac Med, Hematol Lab, Tours, France
[2] Univ Hosp Tours, Tours, France
[3] Fac Med, Dept Med Oncol & Blood Dis, Tours, France
[4] Fac Med, Reg Blood Bank, Tours, France
关键词
D O I
10.1016/S0301-472X(01)00762-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The present study was designed to compare directly the frequency of circulating LTC-IC and E-LTC-IC mobilized in peripheral blood (PB) after chemotherapy supported by either G-CSF (PB-G) or GM-CSF (PB-GM) in comparison to steady-state bone marrow (BM) and PB (PB-ST) values in the same patients. Materials and Methods. Long-term cultures (LTC.) were performed from 20 patients with malignant lymphoma at saturating cell concentrations to assess bulk progenitor cell production and by limiting dilution assay (LDA) to measure both frequency of LTC-IC and their proliferative and differentiation capacities. Results. While CFC production in bulk LTC was higher at weeks 3-5 with PB-G than with PB-GM samples, week-5 LTC-IC and week-10 LTC-IC (E-LTC-IC) frequencies were not different using a LDA. However, the number of CFC derived from a single LTC-IC was higher in PB-G patients than in PB-GM patients (p = 0.01). Interestingly, the frequency of LTC-IC per 1 X 10(5) MNC in mobilized PB positively correlated with one-year marrow progenitor cell recovery, in contrast to the number of autografted CD34(+) cells and CFU-GM per kg. Conclusion. Both G-CSF and GM-CSF resulted in similar increases in LTC-IC and E-LTC-IC in PB at comparable levels to those present in BM. However, the differentiation capacity of LTC-IC was higher after mobilization with G-CSF than with GM-CSF, suggesting qualitative differences in LTC-IC mobilized with these growth factors. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:74 / 81
页数:8
相关论文
共 35 条
[1]   Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma [J].
Aurlien, E ;
Holte, H ;
Pharo, A ;
Kvaloy, S ;
Jakobsen, E ;
Smeland, EB ;
Kvalheim, G .
BONE MARROW TRANSPLANTATION, 1998, 21 (09) :873-878
[2]   Comparative effects of three cytokine regimens after high-dose cyclophosphamide: Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF [J].
Ballestrero, A ;
Ferrando, F ;
Garuti, A ;
Basta, P ;
Gonella, R ;
Stura, P ;
Mela, GS ;
Sessarego, M ;
Gobbi, M ;
Patrone, F .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1296-1303
[3]  
Benboubker L, 1995, EXP HEMATOL, V23, P1568
[4]  
BENDER JG, 1994, BONE MARROW TRANSPL, V13, P479
[5]   CONDITIONS CONTROLLING PROLIFERATION OF HEMATOPOIETIC STEM-CELLS INVITRO [J].
DEXTER, TM ;
ALLEN, TD ;
LAJTHA, LG .
JOURNAL OF CELLULAR PHYSIOLOGY, 1977, 91 (03) :335-344
[6]  
FAZEKAS S, 1982, J IMMUNOL METHODS, V49, P11
[7]   G-CSF versus GM-CSF for stimulation of peripheral blood progenitor cells (PBPC) and leukocytes in healthy volunteers: comparison of efficacy and tolerability [J].
Fischmeister, G ;
Kurz, M ;
Haas, OA ;
Micksche, M ;
Buchinger, P ;
Printz, D ;
Ressmann, G ;
Stroebel, T ;
Peters, C ;
Fritsch, G ;
Gadner, H .
ANNALS OF HEMATOLOGY, 1999, 78 (03) :117-123
[8]  
GIANNI AM, 1989, LANCET, V2, P580
[9]  
Goldschmidt H, 1996, BONE MARROW TRANSPL, V17, P691
[10]   Extended long-term culture reveals a highly quiescent and primitive human hematopoietic progenitor population [J].
Hao, QL ;
Thiemann, FT ;
Petersen, D ;
Smogorzewska, EM ;
Crooks, GM .
BLOOD, 1996, 88 (09) :3306-3313